Beiersdorf AG and Rubedo Life Sciences, Inc., a Sunnyvale, Calif.-based biopharma firm focused on keeping people “biologically young,” have partnered for a multi-year deal to develop anti-aging solutions for the global face market, Beiersdorf announced on 23 April. “The goal of this collaboration is to make use of Rubedo’s cutting-edge research in the field of cellular senescence and Beiersdorf’s market presence to develop groundbreaking anti-aging products,” the Hamburg, Germany-based firm says. Novel compounds with senolytic and anti-inflammatory properties will be sourced from Rubedo’s topical dermatology program.
Beiersdorf Partners With Biopharma For Anti-Aging Skin Care Innovation; Beauty Business News
With NIVEA driving growth in its Consumer division, German firm Beiersdorf AG has signed a multi-year deal with Rubedo Life Sciences to develop anti-aging solutions and new products for the global market. More beauty business news, including L’Oreal, Inter Parfums, Galderma, and LVMH/Sephora sales updates.
More from Strategy
More from Business
• By
Estee Lauder Companies collaborates with Serpin Pharma to explore anti-inflammatory innovation and skin longevity, while L’Oréal Group celebrates the grand opening of North America Research & Innovation Center with ribbon cutting event.
• By
K-beauty (Korean beauty)’s success in US e-commerce in 2024 was independent of overall US market beauty growth, surging 63% year-over-year on average, according to Samsung Securities.
• By
British consumer goods firm Unilever PLC announces it will replace CEO Hein Schumacher with CFO and Executive Director Fernando Fernandez 1 March.